Abstract
Aim:
To explore the association between 801C>T and 847C>T polymorphisms of the human carboxypeptidase E (CPE) gene exon5, which could cause hyperproinsulinemia, and the angiographical characteristics of coronary atherosclerosis.
Methods:
In total, 1044 consecutive patients who underwent coronary angiography for suspected or known coronary atherosclerosis were examined with respect to their genotypes, insulin, proinsulin level, and other risk factors of coronary atherosclerosis. The angiographical characteristics of coronary atherosclerosis (ie the severity of coronary heart disease) were defined by Gensini's score (GS) system.
Results:
The results showed that the genotype frequencies of CC, CT, and TT at 801C>T locus were significantly different among the patients of the 4 groups who were classified by quartile values of GS (P=0.033). However, the frequency of the 847T allele was 0 for all the patients. The ordinal logistic regression analysis revealed that the increased risk of angiographical characteristics of coronary atherosclerosis were associated with CPE 801CT/TT variant genotypes [adjusted odds ratio (OR)=1.23, 95% confidence interval (CI) =0.93-1.63 for 801CT and adjusted OR=3.13, 95% CI=1.18–8.28 for 801TT] compared with the 801CC wild-type homozygotes. A stratification analysis showed that the effects of the CPE 801TT genotype were more evident among subgroups with relatively older (>=60 years) patients, males, and smokers. Furthermore, an analysis of covariance controlling age, sex, and body mass index indicated that differences of blood glucose, insulin, insulin resistance, and the proinsulin level between 801C>T genotype groups were not statistically significant.
Conclusion:
These findings indicate that the 801C>T polymorphism in the CPE exon5 gene may contribute to the angiographical characteristics of coronary atherosclerosis in the Chinese population.
Similar content being viewed by others
Article PDF
References
Utsunomiya N, Ohagi S, Sanke T, Tatsuta H, Hanabusa T, Nanjo K . Organization of the human carboxypeptidase E gene and molecular scanning for mutations in Japanese subjects with NIDDM or obesity. Diabetologia 1998; 41: 701–5.
Chen H, Jawahar S, Qian Y, Duong Q, Chan G, Parker A, et al. Missense polymorphism in the human carboxypeptidase E gene alters enzymatic activity. Hum Mutat 2001; 18: 120–31.
Davies MJ, Rayman G, Gray IP, Day JL, Hales CN . Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 1993; 10: 313–20.
Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr . Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1987; 30: 698–702.
Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, et al. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 1995; 10: 135–42.
Yudkin JS, May M, Elwood P, Yarnell JW, Greenwood R, Davey Smith G . Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study. Diabetologia 2002; 45: 327–36.
Zethelius B, Byberg L, Hales CN, Lithell H, Berne C . Proinsulin is an independent predictor of coronary heart disease: Report from a 27-year follow-up study. Circulation 2002; 105: 2153–8.
Zethelius B, Lithell H, Hales CN, Berne C . Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Diabetologia 2005; 48: 862–7.
Lindahl B, Dinesen B, Eliasson M, Roder M, Jansson JH, Huhtasaari F, et al. High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population. Metabolism 1999; 48: 1197–202.
Lindahl B, Dinesen B, Eliasson M, Roder M, Hallmans G, Stegmayr B . High proinsulin levels precede first-ever stroke in a nondiabetic population. Stroke 2000; 31: 2936–41.
Welborn TA, Wearne K . Coronary heart disease and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2: 154–60.
Ducimetière D, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G . Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980; 19: 205–10.
Pyörälä K, Savolainen S, Kaukola S, Haapakoski J . Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki policemen study population. Acta Med Scand Suppl 1985; 701: 38–52.
Båvenholm P, Proudler A, Tornvall P, Godsland I, Landou C, de Faire U, et al. Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation 1995; 92: 1422–9.
Takezako T, Saku K, Zhang B, Shirai K, Arakawa K . Insulin resistance and angiographical characteristics of coronary atherosclerosis. Jpn Circ J 1999; 63: 666–73.
Judkins MP . A percutaneous transfemoral technique. Radiology 1967; 89: 815–21.
Gensini GG . Coronary arteriography. New York: Mount Kisco Futura Publishing Co; 1975. p 271–4.
Gensini GG . Coronary arteriography. In: Braunwald E, editor. Heart disease. Philadelphia: WB Saunders; 1980. p 352–3.
Gensini GG . A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.
Andersen L, Dinesen B, Jørgensen PN, Poulsen F, Roder ME . Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993; 39: 578–82.
Kjems LL, Roder ME, Dinesen B, Hartling SG, Jorgensen PN, Binder C . Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem 1993; 39: 2146–50.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–9.
Williams RR . Understanding genetic and environmental risk factors in susceptible persons. West J Med 1984; 141: 799–806.
Fricker LD . Peptide processing exopeptidases: amino and cardoxypeptidases involved with peptide biosynthesis. In: Fricker LD, editor, Peptide biosynthesis and processing. Boca Raton: CRC Press; 1991. p 199–228.
Cool DR, Normant E, Shen F, Chen HC, Pannell L, Zhang Y, et al. Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpe (fat) mice. Cell 1997; 88: 73–83.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No 30400173).
Rights and permissions
About this article
Cite this article
Wang, J., Zhang, Y., Yang, Zj. et al. Association of human carboxypeptidase E exon5 gene polymorphisms with angiographical characteristics of coronary atherosclerosis in a Chinese population. Acta Pharmacol Sin 29, 736–744 (2008). https://doi.org/10.1111/j.1745-7254.2008.00798.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00798.x